American Well Co. (NYSE:AMWL) Director Sells $17,302.82 in Stock

American Well Co. (NYSE:AMWLGet Free Report) Director Deborah C. Jackson sold 42,202 shares of American Well stock in a transaction on Monday, June 24th. The stock was sold at an average price of $0.41, for a total transaction of $17,302.82. Following the transaction, the director now owns 636,683 shares in the company, valued at approximately $261,040.03. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

American Well Stock Up 3.3 %

Shares of American Well stock opened at $0.38 on Friday. American Well Co. has a 52 week low of $0.35 and a 52 week high of $2.47. The stock’s 50-day simple moving average is $0.46 and its 200-day simple moving average is $0.86. The company has a market capitalization of $111.20 million, a price-to-earnings ratio of -0.30 and a beta of 1.07.

American Well (NYSE:AMWLGet Free Report) last posted its quarterly earnings results on Wednesday, May 1st. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.07). American Well had a negative return on equity of 46.76% and a negative net margin of 137.32%. The business had revenue of $59.52 million during the quarter, compared to analysts’ expectations of $61.10 million. During the same period in the prior year, the firm posted ($0.24) earnings per share. On average, equities analysts expect that American Well Co. will post -0.75 earnings per share for the current year.

Wall Street Analyst Weigh In

AMWL has been the topic of several analyst reports. Morgan Stanley lowered their target price on American Well from $1.75 to $1.00 and set an “equal weight” rating on the stock in a research report on Monday, April 15th. UBS Group cut their price objective on American Well from $1.50 to $0.60 and set a “neutral” rating for the company in a research note on Thursday, May 23rd. Finally, Needham & Company LLC restated a “hold” rating on shares of American Well in a research note on Thursday, May 2nd.

Check Out Our Latest Analysis on AMWL

Hedge Funds Weigh In On American Well

Several institutional investors have recently bought and sold shares of the stock. Senvest Management LLC boosted its holdings in shares of American Well by 2.2% during the 4th quarter. Senvest Management LLC now owns 23,529,964 shares of the company’s stock valued at $35,060,000 after purchasing an additional 507,340 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of American Well by 1.4% in the first quarter. Vanguard Group Inc. now owns 13,398,096 shares of the company’s stock worth $10,862,000 after buying an additional 190,922 shares in the last quarter. Acadian Asset Management LLC boosted its stake in American Well by 193.0% during the first quarter. Acadian Asset Management LLC now owns 2,083,805 shares of the company’s stock valued at $1,687,000 after buying an additional 1,372,582 shares during the last quarter. Rock Point Advisors LLC grew its holdings in American Well by 9.5% during the 4th quarter. Rock Point Advisors LLC now owns 2,062,582 shares of the company’s stock valued at $3,073,000 after buying an additional 179,061 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in American Well during the first quarter valued at $1,284,000. 56.05% of the stock is owned by hedge funds and other institutional investors.

About American Well

(Get Free Report)

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.

Featured Articles

Insider Buying and Selling by Quarter for American Well (NYSE:AMWL)

Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.